Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome

被引:11
作者
Diz-Kucukkaya, R [1 ]
Demir, K [1 ]
Yenerel, MN [1 ]
Nalcaci, M [1 ]
Kaymakoglu, S [1 ]
Inanc, M [1 ]
机构
[1] Univ Istanbul, Div Haematol, Dept Internal Med, Fac Med, Istanbul, Turkey
关键词
antiphospholipid antibodies; Budd-Chiari syndrome; homozygous factor V Leiden mutation; portal vein thrombosis; recurrent fetal loss; splenic vein thrombosis;
D O I
10.1163/156855902760262790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two female patients are reported, who presented with Budd-Chiari syndrome (hepatic vein thrombosis), and were found to have both, antiphospholipid antibodies and homozygous factor V Leiden mutation. Both patients also had recurrent fetal losses, as well as splenic and portal vein thrombosis, The coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in patients with Budd-Chiari syndrome is extremely rare. The interaction of antiphospholipid antibodies and factor V Leiden mutation in the pathogenesis of antiphospholipid syndrome and their contribution to Budd-Chiari syndrome are discussed.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 20 条
[1]  
AlarconSegovia D, 1996, J RHEUMATOL, V23, P2162
[2]  
Ames PRJ, 1998, THROMB HAEMOSTASIS, V79, P46
[3]  
Ames PRJ, 1996, THROMB HAEMOSTASIS, V76, P190
[4]  
ASHERSON RA, 1991, CLIN EXP RHEUMATOL, V9, P341
[5]   Activated protein C resistance phenotype in patients with antiphospholipid antibodies [J].
Aznar, J ;
Villa, P ;
Espana, F ;
Estelles, A ;
Grancha, S ;
Falco, C .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (02) :202-208
[6]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[8]  
DCRUZ D, 1994, BRIT J RHEUMATOL, V33, P2
[9]   Cause of portal or hepatic venous thrombosis in adults:: The role of multiple concurrent factors [J].
Denninger, MH ;
Chaït, Y ;
Casadevall, N ;
Hillaire, S ;
Guillin, MC ;
Bezeaud, A ;
Erlinger, S ;
Briere, J ;
Valla, D .
HEPATOLOGY, 2000, 31 (03) :587-591
[10]  
Denninger MH, 1997, THROMB HAEMOSTASIS, V78, P1297